top of page


Aunt Bette's Homemade Pecan Pie
Make It
Rockin’ Rocky Road Ice Cream
Make It
Tom’s Heavenly Apple Strudel
Make It
Joe’s Divine Butter Tarts
Make It

Honrao, Chandrashekhar, Nathalie Teissier, Bo Zhang, Robert Powers, and Elizabeth M. O’Day. Gadolinium-based Paramagnetic Relaxation Enhancement Agent Enhances Sensitivity for NUS Multidimensional NMR-based Metabolomics. Molecules, 26(17), 5115; (2021) . 


Honrao, Chandrashekhar, Srihari Raghavendra Rao, Nathalie Teissier, S. Greg Call, Elizabeth M. O’Day, Filip Janku. Plasma-based metabolic profiling in metastatic gastrointestinal stromal tumors (GIST) [abstract]. In: Proceedings of the 112th Annual Meeting of the American Association for Cancer Research; 2021 April 10-15; Virtual. Olaris, Inc., Waltham (MA), MD Anderson Cancer Center, Houston (TX): AACR, 2021. Abstract nr LB031.!/9325/presentation/4540  


Hoyt, L. & O’Day, E. M. Perspective: A potential role for NUS in metabolite-based in vitro diagnostics. Magnetic Resonance in Chemistry 59, 257–263 (2021).  


O’Day, E. M., Idos, G. E., Hill, C., Chen, J. W. & Wagner, G. Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells. OTT 11, 6827–6838 (2018).  


O’Day, E.M., K. Leitzel, A. Lipton, et al. Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer [poster]. In: Proceedings of the 2020 San Antonio Breast Cancer Symposium; San Antonio (TX). Olaris, Inc., Waltham (MA), Penn State Hershey Medical Center, Hershey (PA): SABC, 2020. P4-10-35 


Wolf, Josephine J., Dong, Chen & O’Day, Elizabeth M. Metabolite Biomarkers of Response (BoRs) Towards a Fingerprint for the Evolution of Metastatic Breast Cancer. Progress in Biophysics and Molecular Biology,(2021).  


Zhang, B., Powers, R. & O’Day, E. M. Evaluation of Non-Uniform Sampling 2D 1H–13C HSQC Spectra for Semi-Quantitative Metabolomics. Metabolites 10, 203 (2020).  

Zhang, B., Warner, J., Pinto, C., Juric, D. & ODay, E. NMR-metabolite-resonance signature to predict HR+ breast cancer patient response to CDK4/6 inhibitors. Journal of Clinical Oncology 37, 3043–3043 (2019). 

Zhang, B., Powers, R. & O’Day, E.M. Evaluation of Non-Uniform Sampling 2D 1H–13C HSQC Spectra for Semi-Quantitative Metabolomics [poster]: in Experimental Nuclear Magnetic Resonance Conference; 2020. Olaris, Inc, Waltham (MA),  University of Nebraska-Lincoln, Lincoln (NE): ENC, 2020.  

bottom of page